PATENT CLAIM ANALYSIS

Application Number: 15895883
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "639000"]

Abstract:
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a ribonucleotide reductase allosteric modulator (RRAmod), the amount being effective to inhibit neoplastic cell growth.

Claim (Index 1):
A method of modulating ribonucleotide reductase activity in a neoplastic cell comprising administering to the cell an amount of a ribonucleotide reductase allosteric modulator (RRAmod), the amount being the amount effective to inhibit neoplastic cell growth.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14387151', '13840549', '14029066', '13879101', '11223433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.752540826551155
- 35 USC 102 Novelty (BERT): 0.5670407198440909
- Combined Prediction Score: 0.7339908158804486
- Mean Citation Score: 276.552862
- Max Citation Score: 472.33466
- Similarity Product: 361.4829685760379

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test